Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,407 | 21,734 | 26,593 | 104 | 36,815 |
| TOTAL | $18,134 | $22,833 | $27,907 | $122 | $37,062 |
| Non-Current Assets | |||||
| PPE Net | 27 | 369 | 413 | 30 | 468 |
| Intangibles | 1,223 | 1,223 | 1,223 | 0 | 0 |
| Other Non-Current Assets | 0 | 1,379 | 1,503 | 13 | 143 |
| TOTAL | $1,250 | $2,971 | $3,139 | $42 | $611 |
| Total Assets | $19,384 | $25,804 | $31,046 | $164 | $37,673 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,489 | 1,853 | 2,665 | 1,308 | 591 |
| Accrued Expenses | 1,297 | 638 | 447 | 602 | 918 |
| Other current liabilities | 858 | 1,284 | 1,949 | N/A | 5,180 |
| TOTAL | $3,644 | $4,268 | $5,538 | $1,909 | $6,688 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 774 | 903 | 321 | 0 |
| TOTAL | $157 | $931 | $1,060 | $321 | $N/A |
| Total Liabilities | $3,801 | $5,199 | $6,598 | $2,231 | $6,688 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,779 | 5,177 | 5,177 | 1,575 | 1,566 |
| Common Shares | 2 | 2 | 2 | 1 | 11 |
| Retained earnings | -23,834 | -18,082 | -14,197 | -21,939 | -189,731 |
| TOTAL | $15,583 | $20,606 | $24,448 | $-2,066 | $30,985 |
| Total Liabilities And Equity | $19,384 | $25,804 | $31,046 | $164 | $37,673 |